Hereditary hemorrhagic telangiectasia (HHT) is a systemic angiodysplasia inherited as an autosomal dominant disease. Patients with HHT and pulmonary arteriovenous malformations (PAVMs) are at increased risk for brain abscess (BA), a potentially preventable condition as effective treatment for PAVMs is available. In a center dedicated to HHT, a history of BA was found in 6 out of 128 patients with a definite diagnosis: herewith, their histories are reported focusing on mistakes in the diagnosis and management of the disease. Patients with PAVMs and BA had a higher mean hemoglobin concentration (15.1 g/dl vs. 12.2 g/dl, p < 0.006 by Student’s t test) compared to patients with PAVMs alone. Other clinical features (genetics, bacteriology, types of PAVMs, treatments, outcomes) are also discussed. Prompt diagnosis and screening for visceral involvement is pivotal for HHT patients and their relatives.

Keywords:
Pulmonary arteriovenous malformations, Hereditary hemorrhagic telangiectasia, Brain abscess
1.
Guttmacher AE, Marchuk DA, White RI Jr: Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918–924.
2.
Begbie ME, Wallace GM, Shovlin CL: Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): A view from the 21st century. Postgrad Med J 2003;79:18–24.
3.
Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66–67.
4.
Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, Ma TY, White RI: Pulmonary arteriovenous malformations: Cerebral ischemia and neurologic manifestations. Neurology 2000;55:959–964.
5.
Shovlin CL, Letarte M: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714–729.
6.
Gossage JR, Kanj G: Pulmonary arteriovenous malformations: A state of the art review. Am J Respir Crit Care Med 1998;158:643–661.
7.
Marchesani F, Cecarini L, Pela R, Catalini G, Sabbatini A, Fianchini A, Sanguinetti CM: Pulmonary arteriovenous fistula in a patient with Rendu-Osler-Weber syndrome. Respiration 1997;64:367–370.
8.
Dong SL, Reynolds SF, Steiner IP: Brain abscess in patients with hereditary hemorrhagic telangiectasia: Case report and literature review. J Emerg Med 2001;20:247–251.
9.
White RI Jr, Pollack JS, Wirth JA: Pulmonary arteriovenous malformations: Diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996;7:787–804.
10.
Nicolosi A, Hauser WA, Musicco M, Kurland LT: Incidence and prognosis of brain abscess in a defined population: Olmsted County, Minnesota, 1935–1981. Neuroepidemiology 1991;10:122–131.
11.
Press OW, Ramsey PG: Central nervous system infections associated with hereditary hemorrhagic telangiectasia. Am J Med 1984;77:86–92.
12.
Dutton JA, Jackson JE, Hughes JM, Whyte MK, Peters AM, Ussov W, Allison DJ: Pulmonary arteriovenous malformations: Results of treatment with coil embolization in 53 patients. AJR Am J Roentgenol 1995;165:1119–1125.
13.
Lastella P, Sabbà C, Lenato GM, Resta N, Lattanzi W, Gallitelli M, Cirulli A, GuantiG: Endoglin gene mutations and polymorphisms in Italian patients with hereditary haemorrhagic telangiectasia. Clin Genet 2003;63:536–540.
14.
Shovlin CL, Hughes JM, Scott J, Seidman CE, Seidman JG: Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 1997;61:68–79.
15.
Berg JN, Guttmacher AE, Marchuk DA, Porteous ME: Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996;33:256–257.
16.
Mohler ER, Monahan B, Canty MD, Flockhart DA: Cerebral abscess associated with dental procedure in hereditary haemorrhagic telangiectasia. Lancet 1991;338:508–509.
17.
Victor M, Ropper AH: Infezioni non virali del sistema nervoso centrale e sarcoidosi; in Adams e Victor: Principi di neurologia. Milan, McGraw-Hill, 2002, pp 728–732.
18.
Kuriyama T, Karasawa T, Nakagawa K, Saiki Y, Yamamoto E, Nakamura S: Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:600–608.
19.
Takeshita M, Kagawa M, Yonetani H, Izawa M, Yato S, Nakanishi T, Monma K: Risk factors for brain abscess in patients with congenital cyanotic heart disease. Neurol Med Chir (Tokyo) 1992;32:667–670.
20.
Mager JJ, Zanen P, Verzijlbergen F, Westermann CJ, Haitjema T, van Herk G, Lammers JW: Quantification of right-to-left shunt with 99mTc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia. Clin Sci (Lond) 2002;102:127–134.
21.
Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH, White RI Jr: Diffuse pulmonary arteriovenous malformations: Characteristics and prognosis. Chest 2000;117:31–38.
22.
Quaden C, Ghaye B, Dondelinger RF, Belaiche J, Bartsch P, Cataldo DD: Multiple pulmonary arteriovenous malformations. Lancet 2002;359:1998.
23.
Blanco P, Schaeverbeke T, Baillet L, Lequen L, Bannwarth B, Dehais J: Rendu-Osler familial telangiectasia angiomatosis and bacterial spondylodiscitis. Rev Med Interne 1998;19:938–939.
24.
David C, Brasme L, Peruzzi P, Bertault R, Vinsonneau M, Ingrand D: Intramedullary abscess of the spinal cord in a patient with a right-to-left shunt: Case report. Clin Infect Dis 1997;24:89–90.
25.
Lu CH, Chang WN, Lin YC, Tsai NW, Liliang PC, Su TM, Rau CS, Tsai YD, Liang CL, Chang CJ, Lee PY, Chang HW, Wu JJ: Bacterial brain abscess: Microbiological features, epidemiological trends and therapeutic outcomes. QJM 2002;95:501–509.
26.
Brydon HL, Akinwunmi J, Selway R, Ul-Haq I: Brain abscesses associated with pulmonary arteriovenous malformations. Br J Neurosurg 1999;13:265–269.
27.
Heilpern KL, Lorber B: Focal intracranial infections. Infect Dis Clin North Am 1996;10:879–898.
28.
Rosenblum ML, Hoff JT, Norman D, Weinstein PR, Pitts L: Decreased mortality from brain abscesses since advent of computerized tomography. J Neurosurg 1978;49:658–668.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.